Randomized trial investigates thrombectomy outcomes for M2 occlusions, revealing the importance of stroke severity in treatment decisions.
Recent randomized trials reported no overall functional benefit of endovascular treatment (EVT) for distal medium-vessel occlusion (DMVO) and did not identify consistent effect modifiers to guide patient selection. Consequently, the role of EVT—particularly for M2 occlusions—remains controversial. We investigated whether baseline clinical severity modifies the association between successful recanalization and 90-day outcome in patients with M2 occlusion.
No takes yet. Share an insight, caveat, or question.
Broocks et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: